Why tumors become resistant to chemotherapy?
IDIBELL Researchers describe epigenetic changes that explain the lack of response to drugs in colon cancer Article reference
Why tumors become resistant to chemotherapy? Read More »
IDIBELL Researchers describe epigenetic changes that explain the lack of response to drugs in colon cancer Article reference
Why tumors become resistant to chemotherapy? Read More »
IDIBELL researcher Manel Esteller has been awarded in the category of basic research
Princess of Asturias delivers King Jaime I Awards 2013 Read More »
Inhibition of the complement system protects the transplant of pig cartilage cells Complement system Description of the mechanism Cartilage transplant
Influenza virus attacks us every year and occasionally can cause pandemics with high morbidity and mortality. This virus is the object of study team led by researcher John Ortín the National Center of Biotechnology, CSIC, Madrid. Juan Ortín explained in a conference within IDIBELL seminars on 8 November, the progress of his research on the
Juan Ortin:”The defining characteristic of influenza virus is its unpredictability” Read More »
ICO , IDIBELL and HUB are part of this network that aims to position health research is done in Catalonia in Europe
Health Connect-EU presents Strategic Agenda in Health Research 2013 Read More »
The Catalan Institute of Oncology (ICO) has published its first sustainability report, which has been developed according to the criteria of the Global Reporting Initiative (GRI) Level A, maximum application. The report, which has been approved by the Management Board, follows the strategic lines of the institution, which has among its objectives to ensure the
ICO publishes 2012 sustainability report Read More »
Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Research Professor and Professor of Genetics at the University of Barcelona, has been recognized as one of the most influential scientists in the area of biomedicine according to a recent bibliometric study. The work of Stanford University
The head of the department of neurology at the Hospital de Sant Pau and Santa Cruz de Barcelona, Alberto Lleó, explained the latest developments in the investigation of the molecular mechanisms that lead to Alzheimer’s disease. It was last October 25 as part of the seminars IDIBELL. Lleó group works on a multimodal approach in